MetLife Investment Management, LLC - HARMONY BIOSCIENCES HLDGS IN ownership

HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 213 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.7%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of HARMONY BIOSCIENCES HLDGS IN
ValueSharesWeighting
Q3 2023$575,015
-6.9%
17,5470.0%0.01%0.0%
Q2 2023$617,479
+32.5%
17,547
+22.9%
0.01%
+66.7%
Q1 2023$465,981
-40.7%
14,2720.0%0.00%
-50.0%
Q4 2022$786,387
+24.4%
14,2720.0%0.01%
+20.0%
Q3 2022$632,107
-9.2%
14,2720.0%0.01%
-16.7%
Q2 2022$696,045
+4.5%
14,272
+4.2%
0.01%
+50.0%
Q1 2022$666,359
+67.4%
13,697
+46.7%
0.00%
+33.3%
Q4 2021$398,130
+11.2%
9,3370.0%0.00%0.0%
Q3 2021$357,887
+35.8%
9,3370.0%0.00%0.0%
Q2 2021$263,5849,3370.00%
Other shareholders
HARMONY BIOSCIENCES HLDGS IN shareholders Q1 2023
NameSharesValueWeighting ↓
Valor Management LLC 11,218,033$367,614,94198.94%
Nan Fung Group Holdings Ltd 368,665$12,081,1529.78%
venBio Partners LLC 1,035,396$33,929,9279.62%
Vivo Capital, LLC 2,606,247$85,406,7149.36%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 314,500$10,306,1653.47%
AlphaCentric Advisors LLC 122,000$3,997,9402.27%
ASHFORD CAPITAL MANAGEMENT INC 434,148$14,227,0302.09%
Altium Capital Management LP 117,000$3,834,0902.00%
NEUMEIER POMA INVESTMENT COUNSEL LLC 595,490$19,514,2071.90%
TANG CAPITAL MANAGEMENT LLC 271,200$8,887,2241.25%
View complete list of HARMONY BIOSCIENCES HLDGS IN shareholders